Priya Dalvi

890 total citations
10 papers, 166 citations indexed

About

Priya Dalvi is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Priya Dalvi has authored 10 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Priya Dalvi's work include Epigenetics and DNA Methylation (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Single-cell and spatial transcriptomics (2 papers). Priya Dalvi is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Single-cell and spatial transcriptomics (2 papers). Priya Dalvi collaborates with scholars based in Germany, United Kingdom and China. Priya Dalvi's co-authors include Margarete Odenthal, Marion Müller, Edward J. Ryder, Debarati Sethi, Diane Gleeson, Soyoung Lim, Joanna Bottomley, Richard Houghton, Ramiro Ramírez‐Solis and Hannah Wardle‐Jones and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

In The Last Decade

Priya Dalvi

10 papers receiving 164 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priya Dalvi Germany 7 122 31 29 23 22 10 166
Emilia Kuuluvainen Finland 6 151 1.2× 46 1.5× 27 0.9× 25 1.1× 20 0.9× 11 219
E.M.S.F. Ribeiro Brazil 7 90 0.7× 44 1.4× 39 1.3× 22 1.0× 10 0.5× 12 145
Saya H. Ebbesen United States 3 90 0.7× 45 1.5× 23 0.8× 12 0.5× 13 0.6× 3 123
Salvador Alejo United States 9 193 1.6× 46 1.5× 37 1.3× 29 1.3× 12 0.5× 14 240
Veronica Saenz-Vash Switzerland 5 181 1.5× 27 0.9× 28 1.0× 27 1.2× 7 0.3× 5 223
Hanane Agherbi France 5 266 2.2× 36 1.2× 39 1.3× 26 1.1× 27 1.2× 8 319
Deniz Demircioğlu United States 6 133 1.1× 40 1.3× 56 1.9× 13 0.6× 32 1.5× 12 204
Zhi Jiang Zang Singapore 5 91 0.7× 46 1.5× 33 1.1× 33 1.4× 24 1.1× 5 142
Edwin Oole Netherlands 6 119 1.0× 17 0.5× 17 0.6× 23 1.0× 60 2.7× 8 222
William Luther United States 4 79 0.6× 46 1.5× 37 1.3× 16 0.7× 29 1.3× 4 178

Countries citing papers authored by Priya Dalvi

Since Specialization
Citations

This map shows the geographic impact of Priya Dalvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priya Dalvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priya Dalvi more than expected).

Fields of papers citing papers by Priya Dalvi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priya Dalvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priya Dalvi. The network helps show where Priya Dalvi may publish in the future.

Co-authorship network of co-authors of Priya Dalvi

This figure shows the co-authorship network connecting the top 25 collaborators of Priya Dalvi. A scholar is included among the top collaborators of Priya Dalvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priya Dalvi. Priya Dalvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Nestler, Tim, Priya Dalvi, Friederike Haidl, et al.. (2022). Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumours. British Journal of Cancer. 126(6). 937–947. 11 indexed citations
2.
Dalvi, Priya, et al.. (2021). Reprogramming of glutamine metabolism by epigenetic modifier LSD1 regulates chemotherapy resistance in PDAC. Pancreatology. 21. S67–S67. 1 indexed citations
3.
Wu, Fengying, Jue Fan, Jingwen Fang, et al.. (2020). Single Cell Sequencing: A New Dimension in Cancer Diagnosis and Treatment. Advances in experimental medicine and biology. 1255. 109–121. 4 indexed citations
4.
Dalvi, Priya, Udo Siebolts, Claudia Wickenhauser, et al.. (2020). Expression profiling on subclasses of primary parotid gland carcinomas. Oncotarget. 11(45). 4123–4137. 6 indexed citations
5.
Dalvi, Priya, Soyoung Lim, Marion Müller, et al.. (2019). LSD1 Inhibition Attenuates Tumor Growth by Disrupting PLK1 Mitotic Pathway. Molecular Cancer Research. 17(6). 1326–1337. 17 indexed citations
6.
Nestler, Tim, Friederike Haidl, Maike Wittersheim, et al.. (2019). Comprehensive analysis of metastatic seminoma germ cell tumors shows divergent expression of immune-related pathways.. Journal of Clinical Oncology. 37(7_suppl). 506–506. 12 indexed citations
7.
Dalvi, Priya, Soyoung Lim, Lydia Meder, et al.. (2018). Preclinical studies reveal that LSD1 inhibition results in tumor growth arrest in lung adenocarcinoma independently of driver mutations. Molecular Oncology. 12(11). 1965–1979. 27 indexed citations
8.
Lim, Soyoung, Priya Dalvi, Stephan Schäfer, et al.. (2017). LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells. Scientific Reports. 7(1). 10292–10292. 9 indexed citations
9.
Ryder, Edward J., Brendan Doe, Diane Gleeson, et al.. (2013). Rapid conversion of EUCOMM/KOMP-CSD alleles in mouse embryos using a cell-permeable Cre recombinase. Transgenic Research. 23(1). 177–185. 35 indexed citations
10.
Ryder, Edward J., Diane Gleeson, Debarati Sethi, et al.. (2013). Molecular Characterization of Mutant Mouse Strains Generated from the EUCOMM/KOMP-CSD ES Cell Resource. Mammalian Genome. 24(7-8). 286–294. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026